Statistical analysis of PML incidences of natalizumab-treated patients from 2009 to 2016: outcomes after introduction of the Stratify JCV® DxSelect™ antibody assay

Detalles Bibliográficos
Autores principales: Campagnolo, Denise, Dong, Qunming, Lee, Lily, Ho, Pei-Ran, Amarante, Diogo, Koendgen, Harold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127882/
https://www.ncbi.nlm.nih.gov/pubmed/27730447
http://dx.doi.org/10.1007/s13365-016-0482-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5127882/
https://www.ncbi.nlm.nih.gov/pubmed/27730447
http://dx.doi.org/10.1007/s13365-016-0482-z

Ejemplares similares